AUPH R&D to Revenue
Aurinia Pharmaceuticals Inc · R&D to Revenue
AUPH R&D to Revenue
Latest reported11.48%period ending
AUPH FY R&D/Revenue (183.33% → 11.48%)
Latest values, visible window
High-resolution chart · PNG
AUPH r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 11.4836% | |
| 8.8397% | |
| 28.2834% | |
| 33.5656% | |
| 112.1346% | |
| 100.417% | |
| 16,624.5283% | |
| 8,937.797% | |
| 8,078.5714% | |
| 8,401.1561% | |
| 6,800.8511% | |
| 3,277.6978% | |
| 203.8614% | |
| 89.4711% | |
| 374.7623% | |
| 116.6326% | |
| 188.8287% | |
| 295.1674% | |
| 1,272.0156% | |
| 539.4788% | |
| 1,650.8782% | |
| 1,061.5938% | |
| 119.084% | |
| 59.629% | |
| 158.7573% | |
| 529.2933% | |
| 105% | |
| 183.3332% |